BARDA is seeking new partners with preparedness and commercial applications in the following priority areas for general and at-risk populations (including pediatrics):
- Pandemic influenza and emerging infectious diseases
- Alternative vaccine and drug delivery techniques
- Early and/or pre-symptomatic disease detection
- Advanced manufacturing capabilities
- Point-of-care diagnostics for use outside of medical settings
- Disruptive and non-traditional modalities for addressing antimicrobial resistance
- Approaches to address sepsis